NASDAQ:BABY - Natus Medical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $26.37 -0.44 (-1.64 %) (As of 05/24/2019 01:08 AM ET)Previous Close$26.81Today's Range$26.31 - $26.9552-Week Range$23.58 - $37.95Volume206,061 shsAverage Volume344,436 shsMarket Capitalization$896.74 millionP/E Ratio18.57Dividend YieldN/ABeta0.54 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California. Receive BABY News and Ratings via Email Sign-up to receive the latest news and ratings for BABY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:BABY Previous Symbol CUSIP63905010 CIK878526 Webhttp://www.natus.com/ Phone925-223-6700Debt Debt-to-Equity Ratio0.18 Current Ratio1.70 Quick Ratio1.18Price-To-Earnings Trailing P/E Ratio18.57 Forward P/E Ratio20.76 P/E GrowthN/A Sales & Book Value Annual Sales$530.89 million Price / Sales1.69 Cash Flow$2.8173 per share Price / Cash Flow9.36 Book Value$10.81 per share Price / Book2.44Profitability EPS (Most Recent Fiscal Year)$1.42 Net Income$-22,930,000.00 Net Margins-8.62% Return on Equity10.75% Return on Assets6.56%Miscellaneous Employees1,729 Outstanding Shares34,006,000Market Cap$896.74 million Next Earnings Date7/24/2019 (Estimated) OptionableOptionable Natus Medical (NASDAQ:BABY) Frequently Asked Questions What is Natus Medical's stock symbol? Natus Medical trades on the NASDAQ under the ticker symbol "BABY." How will Natus Medical's stock buyback program work? Natus Medical declared that its Board of Directors has initiated a stock repurchase plan on Thursday, February 22nd 2018, which authorizes the company to repurchase $30,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase plans are often an indication that the company's management believes its stock is undervalued. How were Natus Medical's earnings last quarter? Natus Medical Inc (NASDAQ:BABY) issued its earnings results on Thursday, April, 25th. The medical equipment provider reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.03. The medical equipment provider earned $114.80 million during the quarter, compared to analyst estimates of $113.30 million. Natus Medical had a negative net margin of 8.62% and a positive return on equity of 10.75%. The company's revenue for the quarter was down 10.7% compared to the same quarter last year. During the same period last year, the firm posted $0.24 EPS. View Natus Medical's Earnings History. When is Natus Medical's next earnings date? Natus Medical is scheduled to release their next quarterly earnings announcement on Wednesday, July 24th 2019. View Earnings Estimates for Natus Medical. What guidance has Natus Medical issued on next quarter's earnings? Natus Medical updated its FY19 earnings guidance on Thursday, April, 25th. The company provided EPS guidance of $1.17-1.44 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.28. The company issued revenue guidance of $498.90 million, compared to the consensus revenue estimate of prior $1.12-1.49.Natus Medical also updated its Q2 guidance to $0.25-0.32 EPS. What price target have analysts set for BABY? 2 analysts have issued 12 month target prices for Natus Medical's shares. Their forecasts range from $36.00 to $36.00. On average, they expect Natus Medical's stock price to reach $36.00 in the next twelve months. This suggests a possible upside of 36.5% from the stock's current price. View Analyst Price Targets for Natus Medical. What is the consensus analysts' recommendation for Natus Medical? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Natus Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Natus Medical. Has Natus Medical been receiving favorable news coverage? News coverage about BABY stock has trended somewhat positive on Thursday, according to InfoTrie. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Natus Medical earned a media sentiment score of 1.9 on InfoTrie's scale. They also assigned press coverage about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. Who are some of Natus Medical's key competitors? Some companies that are related to Natus Medical include LivaNova (LIVN), GETINGE AB/ADR (GNGBY), CONMED (CNMD), NxStage Medical (NXTM), AxoGen (AXGN), Viewray (VRAY), TransMedics Group (TMDX), BioLife Solutions (BLFS), Semler Scientific (SMLR), Rockwell Medical (RMTI), Cutera (CUTR), Zynex (ZYXI), BioSig Technologies (BSGM), Stereotaxis (STXS) and Fonar (FONR). What other stocks do shareholders of Natus Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Natus Medical investors own include Gilead Sciences (GILD), Starbucks (SBUX), Walt Disney (DIS), Activision Blizzard (ATVI), Intel (INTC), Celgene (CELG), Alphabet (GOOG), Skyworks Solutions (SWKS), NVIDIA (NVDA) and Tesla (TSLA). Who are Natus Medical's key executives? Natus Medical's management team includes the folowing people: Mr. Jonathan A. Kennedy CPA, Pres, CEO & Director (Age 48)Mr. Benjamin Drew Davies, Exec. VP & CFO (Age 53)Mr. Austin F. Noll III, Exec. VP & Chief Commercial Officer (Age 52)Mr. Seán Langan, VP Global OperationsMr. Ivan Pandiyan, VP of Global R&D Who are Natus Medical's major shareholders? Natus Medical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.94%), Janus Henderson Group PLC (9.61%), Dimensional Fund Advisors LP (4.74%), Wellington Management Group LLP (3.02%), Northern Trust Corp (1.56%) and Rutabaga Capital Management LLC MA (1.41%). Company insiders that own Natus Medical stock include Austin Francis Noll III, Dong Chune Christopher Chung, Doris Engibous, James B Hawkins, Jonathan Kennedy, Ken Ludlum, Lisa Wipperman Heine, Robert A Gunst and William M Moore. View Institutional Ownership Trends for Natus Medical. Which institutional investors are selling Natus Medical stock? BABY stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, BNP Paribas Arbitrage SA, BlackRock Inc., JPMorgan Chase & Co., Diamond Hill Capital Management Inc., Clean Yield Group, Wellington Management Group LLP and Ladenburg Thalmann Financial Services Inc.. Company insiders that have sold Natus Medical company stock in the last year include Austin Francis Noll III, Dong Chune Christopher Chung, Jonathan Kennedy, Ken Ludlum and Robert A Gunst. View Insider Buying and Selling for Natus Medical. Which institutional investors are buying Natus Medical stock? BABY stock was bought by a variety of institutional investors in the last quarter, including WCM Investment Management LLC, Martingale Asset Management L P, Rutabaga Capital Management LLC MA, Marshall Wace LLP, Morgan Stanley, Charles Schwab Investment Management Inc., Cornercap Investment Counsel Inc. and Alambic Investment Management L.P.. Company insiders that have bought Natus Medical stock in the last two years include James B Hawkins and Lisa Wipperman Heine. View Insider Buying and Selling for Natus Medical. How do I buy shares of Natus Medical? Shares of BABY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Natus Medical's stock price today? One share of BABY stock can currently be purchased for approximately $26.37. How big of a company is Natus Medical? Natus Medical has a market capitalization of $896.74 million and generates $530.89 million in revenue each year. The medical equipment provider earns $-22,930,000.00 in net income (profit) each year or $1.42 on an earnings per share basis. Natus Medical employs 1,729 workers across the globe. What is Natus Medical's official website? The official website for Natus Medical is http://www.natus.com/. How can I contact Natus Medical? Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The medical equipment provider can be reached via phone at 925-223-6700 or via email at [email protected] MarketBeat Community Rating for Natus Medical (NASDAQ BABY)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 261 (Vote Outperform)Underperform Votes: 282 (Vote Underperform)Total Votes: 543MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote "Outperform" if you believe BABY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BABY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: Growth Stocks Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.